Featured Opinions
Pharma and the new YouTube layout
by EileenOBrien
A review of the most pharma-relevant changes to YouTube
M’s the word: Second thoughts on riding the excitement
How I learned to love the iPad a little bit less
Adherence Arena: Overcoming the fear of adverse events
Patients need to know the risks of non-adherence as much as the risks of medication
The value of making content easy to share
by EileenOBrien
Providing shareworthy content is one thing pharmaceutical companies can do well
Adherence and patient support programs
Michael Clayton, director of strategy, Atlantis Healthcare Australia, on how patient support programs can connect patients with information and help them achieve behavioral change
M’s the word: Pharma’s got talent
Why pharma should recruit faster when replacing key talent
Technology, adherence and patient partnerships
Jeanne Barnett on how pharma can use games to engage patients and improve adherence
M’s the word: Teaching the giants to dance
Pharma needs a little spring in its step
How to connect with physicians online
by EileenOBrien
What social sites physicians use—and why they use them
M’s the Word: In praise of imperfection
Bring back personal service, however imperfect it may be
M’s the Word: Regaining ‘pride in the job’
What I learned about efficiency and proficiency from a trip to Seoul
Sell Drugs: Innovation Special
by Anonymous (not verified)
In a new wave of innovations, yesterday, 20,000 jobs were innovated in R&D at Beezer Pharmaceuticals.
Placing the power of health back with the patient
Lessons from eyeforpharma’s 2011 Patient Adherence, Communication and Engagement Summit
SellDrugs: Perfect balance found
by Anonymous (not verified)
Yesterday, perfect balance was found, a state of sublime poise between the efficacy and safety of bolloxizumab.
M’s the Word: Marketing’s reality check
Have we marketers pitched the promised land just too far out of reach?
Mal’s Musings: What pharma can learn from FMCG marketing
Is pharma’s real challenge brand loyalty or patient adherence?
5 ways to win at business acumen
by Steven Rosen
The next evolution of the sales rep is into a business person
How to use social media to activate a community around a rare disease
Key strategies for pharma’s emerging markets
by Mary Wieder
Why emerging markets are the industry’s best hope for growth
Pharma and online communities: What you should know
by EileenOBrien
The pros and cons of online health communities
Pharma and computer system validation
by Mary Wieder
Why computer system validation (CSV) is important for the life sciences industry
Why don’t doctors care about adherence?
by Ian De'Ath
Adherence matters, and it needs to matter more